Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dosage and administration of anti-C5 antibodies for treatment of atypical hemolytic uremic syndrome (aHUS) in pediatric patients

Dosage and administration of anti-C5 antibodies for treatment of atypical hemolytic uremic syndrome (aHUS) in pediatric patients

US Patent 12460012 · Granted Nov 4, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Information transmission method and communications apparatus2025
Wireless charging transmitter and method for controlling the wireless charging t2025
Antenna apparatus, method for producing antenna apparatus, radar, and terminal2025
Audio playing method, electronic device, and storage medium2025
Robust dispatch method for flexibility resources of large-scale data center micr2025
Multiple and sinusoidal pulse width modulation for wireless charging2025
Isobaric stable isotope-containing phosphorylated protein labeling reagent, and 2025
Large language model performance evaluation and modification2025
Placing hard macros using machine learning predictions trained on different circ2025
Communication method and device2025
Dosage and administration of anti-C5 antibodies for treatment of paroxysmal noct2025
Dosage and administration of anti-C5 antibodies for treatment of paroxysmal noct2025